ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Par Health clinical trials

The registry lists 41 studies whose lead sponsor is Par Health or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2017.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

What it is testing

The drugs Par Health’s studies test, most studies first; none is open now — 23 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 13 more

All 41 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed3380%
  • Stopped early512%
  • Status unknown or other37%

Phase

  • Phase 130
  • Phase 37
  • Phase 24

Where

  • Canada14
  • United States14
  • Puerto Rico1

Over the years

  1. 11
  2. 12
  3. 413
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 026

By the year each study started; 33 started before 2011. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Par Health.

  • Par Pharmaceutical, Inc.
    Acquired — became part of Par Health, Nov 10, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies →
  • JHP Pharmaceuticals LLC
    Acquired — became part of Par Health, Nov 10, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Anchen Pharmaceuticals, Inc
    Acquired — became part of Par Health, Nov 10, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions Par Health leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 41 of 41.